Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea

International Journal of STD and AIDS

Volumn 15, Issue 4, 2004, Pages 240-242

  Habib, Amgad R ^a,b   Fernando, Rufus ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Azithromycin; Chlamydial co infection; Neisseria gonorrhoeae; Uncomplicated gonorrhoea

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; PENICILLIN G; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; GONORRHEA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 2342574187     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646204773557767     Document Type: Article

References (16)

1. Waugh MA. Azithromycin in gonorrhoea. Int J STD AIDS 1996;7(Suppl 1):2-4
2. Ridgway GL. Azithromycin in sexually transmitted diseases. Int J STD AIDS 1996;7(Suppl 1):1
3. Retsema J, Girrard A, Shelky W, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered ring macrolide with improved potency against gram negative organisms. Antimicrob Agents Chemother 1987;31:1939-47
4. Girard AE, Girard E, English AR, et al. Pharmacokinetic and in vivo studies with azithromycin (CP-69,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 1987;31:1948-54
5. Ridgway GL. Azithromycin in the management of Chlamydia trachomatis infection. Int J STD AIDS 1996;7(Suppl 1):5-8
6. Slaney L, Chubb H, Ronald AR, Brunham R. In vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Hemophilus ducreyi and Chlamydia trachomatis. J Antimicrob Chemother 1990;25(Suppl A):1-5
7. Scieux C, Bianchi A, Chappey B, Vassias I, Pérol Y. In vitro activity of azithromycin against C. trachomatis. J Antimicrob Chemother 1990;25(Suppl A):7-10
8. Martin D H, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992;327:921-5
9. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991;2:248-51
10. Stratton CW, Cooksey RC. Susceptibility tests: special tests. In: Balows A, et al, eds. Manual of Clinical Microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1991:1153-65
11. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994;21:43-6
12. Handsfield HH, Dalu ZA, Martin DH, Douglas JM, McCarty JM, Schlossberg D. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis 1994;21:107-11
13. Odugbemi T, Oyewole F, Isichei CS, Onwukeme KE, Adeyemi-Doro FA. Single oral dose azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation. West Afr J Medicine 1993;12:136-40
14. Gordon SM, Carlyn CJ, Doyle LJ, et al. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med 1996;125:465-70
15. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;255(Suppl A):73-82
16. Ehret JM, Nims LJ, Judson FN. A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. Sex Transm Dis 1996;23:270-2